The New Trust Imperative

If you’re a working parent like me, you know the deal: It’s a daily balancing act to meet the demands of work, home, and health, while running on a few hours of sleep (and maybe a really big cup of coffee). You carve out precious time in your week for an appointment with your doctor. You explain your concerns and how you’re feeling, but their eyes stay fixed on a screen as they take notes. Then comes the checklist: “Make sure you’re getting 8 hours of sleep” and “aim for 30 minutes of exercise per day.”

It’s not that the advice is wrong. It just doesn’t feel connected to you or the personal realities that make healthy living challenging. When doctor visits feel transactional and generic, it’s difficult to feel understood, let alone motivated to make a change. If we reflect on moments like these in our own healthcare experiences, we start to see how patients must feel when they encounter messaging meant to be educational, but that’s overly clinical, tightly constrained, and emotionally detached. That sense of disinterest erodes trust, and without trust, we’ve lost the mission to reach patients before it even begins.

When Content Ignores the Person Behind the Patient
We see this same disconnect in healthcare marketing:

    • A powerful patient story is distilled into a one-sentence MLR-approved soundbite
    • Warm, empathetic lines—“You’re stronger than you think” or “You are a warrior”—are removed because they can’t be referenced verbatim
    • Messages of resilience and inspiration are stripped out because they aren’t directly supported by a clinical practice guideline or peer-reviewed article

There’s an underlying fear in pharma marketing that if you can’t reference it, you can’t say it. But patients don’t speak in citations—they speak in the frustrations, tradeoffs, and goals of their daily lives. And if it’s not our place as healthcare marketers to acknowledge these realities, whose place is it? Clinicians often don’t have the time, the system isn’t built for it, and yet patients deeply need it.

Evidence supports this need. For example, in a PLoS One analysis of nationally representative US survey data, researchers found that when patients perceived communication during office visits as more patient‑centered, they were more likely to trust the information their clinicians provided.1

Even Good Information Can Fall Short
Imagine a patient recently diagnosed with gestational diabetes, a moment already filled with fear, confusion, and urgency. She meets with a nutritionist hoping for guidance, partnership, and maybe the reassuring sense of you’ve got this. Instead, she gets a rapid‑fire lecture on glucose levels, carb-counting, and portion control. No one asks her:

    • What does food mean in your culture? In your household?
    • Are you also cooking for other family members with other dietary needs?
    • Do you have the time for meal prep?
    • Do you have the budget for or access to high quality whole foods?

Without understanding her context, even wellintentioned education becomes noise. The same dynamic plays out in healthcare marketing too. When messaging doesn’t meet patients where they are—emotionally, practically, and culturally—it’s easy to tune out. And the chance to transform information into actions that patients can realistically take to improve their health slips away.

“Let AI handle efficiency so humans can handle empathy.”

But Regulatory Pressure Is Higher Than Ever
At the same time, FDA scrutiny has intensified. In fiscal year 2025, the FDA issued more than 300 warning letters, representing a 59% increase from the previous year. About half of these letters (47%) pertained to website, labeling, and/or promotional communications review.2 Accuracy, transparency, and contextual integrity are non-negotiable, but how do we balance compliance with humanity?

How do we walk that line between what we can say and what patients need to hear?

Compliance Checks the Boxes, but Humanity Builds Trust
The answer is not to retreat into sterile language. The answer is to build smarter, more nuanced, evidence-aligned communications that still speak to people as people. Here’s how:

1. Start with real patient context. Ground education in lived experience—cultural norms, time constraints, family dynamics, and social determinants of health. When we understand the why behind patient behavior, our content becomes meaningful instead of mechanical.

2. Blend evidence with humanity. We can stay fully compliant while still sounding human. Use supportive, empathetic language that acknowledges difficulty without implying clinical claims. Accuracy and warmth are not mutually exclusive.

3. Use clinical experts to keep education realistic. Partner with healthcare professionals to ensure content is medically sound, achievable, and aligned with real-world practice, not idealized scenarios most patients can’t relate to.

4. Deliver modular, customizable education. Build flexible content that adapts for different cultural, emotional, and lifestyle needs. This keeps materials relevant without ever personalizing it to identifiable data.

5. Let AI handle efficiency so humans can handle empathy. As a tool, AI can help streamline labor-intensive tasks, like summarizing references and organizing insights, freeing up creative teams to focus on nuance, connection, and context of content and how it’s delivered.

When we balance accuracy with empathy, evidence with relevance, and compliance with compassion, we create communications that don’t just avoid FDA violations—we earn trust. And trust is the engine that drives everything else that follows: engagement, adherence, clinical dialogue, brand reputation, and meaningful long-term impact.

 

REFERENCES:
1. Asan O, Yu Z, Crotty BH. How clinician-patient communication affects trust in health information sources: Temporal trends from a national cross-sectional survey. PLoS One. 2021;16(2):e0247583. doi: 10.1371/journal.pone.0247583
2. Hartmann E, Oestreich L. Trends in FDA FY 2025 Warning Letters. March 13, 2026. Accessed April 1, 2026. https://www.pharmaceuticalonline.com/doc/trends-in-fda-fy-2025-warningletters-00011